Immunization with a DNA expression vector encoding the varicella zoster virus glycoprotein E (gE) gene via intramuscular and subcutaneous routes

By Hasan U.A.   Harper D.R.   Argent S.   Layton G.   Wren B.W.   Morrow W.J.W.  

Vaccine, Vol. 18, Iss. 15, 2000-02 ,pp. : 1506-1514

Elsevier

Access to resources Recommend Favorite

Boosting immune response with a candidate varicella-zoster virus glycoprotein subunit vaccine

By Vafai A.  

Vaccine, Vol. 13, Iss. 14, 1995-10 ,pp. : 1336-1338

Elsevier

Access to resources Recommend Favorite

Nucleotide sequence analysis of varicella-zoster virus glycoprotein E epitope coding regions

By Shankar V.   Fisher S.   Forghani B.   Vafai A.  

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 3830-3833

Elsevier

Access to resources Recommend Favorite

Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation

By Jacquet A.   Haumont M.   Massaer M.   Garcia L.   Mazzu P.   Daminet V.   Gregoire D.   Jacobs P.   Bollen A.  

Vaccine, Vol. 20, Iss. 11, 2002-02 ,pp. : 1593-1602

Elsevier

Access to resources Recommend Favorite

Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge

By Men R.   Wyatt L.   Tokimatsu I.   Arakaki S.   Shameem G.   Elkins R.   Chanock R.   Moss B.   Lai C.-J.  

Vaccine, Vol. 18, Iss. 27, 2000-07 ,pp. : 3113-3122

Elsevier

Access to resources Recommend Favorite